Tonix Pharmaceuticals (TNXP) stock gains as the company posts peer-reviewed data for pain drug TNX-102 and new data for mpox ...

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) saw its stock rise 2% after unveiling new preclinical findings for its ...

TNX-801 is up to 100,000-fold less virulent than live smallpox vaccine strains and a single dose provides robust immunogenicity and protection against mpox and rabbitpox (more than one year) in ...

Tonix Pharmaceuticals (NASDAQ: TNXP) , a fully integrated biopharmaceutical company, announced that Dr. Sina Bavari, Executive Vice President of Infe ...

Single dose vaccination with TNX-801 protects animals from a lethal challenge with monkeypox, the causative agent of mpox TNX ...

Tonix Pharmaceuticals (NASDAQ: TNXP) , a fully integrated biotech company, announced its inclusion in the Russell 3000® and Russell 2000® Indexes fol ...

The leading Post-Traumatic Stress Disorder Companies such as Tonix Pharmaceuticals, Inc., Pop Test Oncology LLC, H. Lundbeck A/S, Bionomics Limited, Alto Neuroscience, Transcend Therapeutics and ...

Tonix Pharmaceuticals (NASDAQ:TNXP) announced on Monday an addition to the broad-market Russell 3000 Index and an automatic inclusion in the small-cap Russell 2000 Index. Shares were +0.32% pre-market ...

“Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stock gained on optimism for the launch of its new drug Journavx, a non-opioid painkiller for acute pain and the first new class of pain ...

Sun Pharma appoints Richard Ascroft as North America CEO to lead U.S. and Canada operations, including new drug launches and NJ HQ expansion.

Complete Tonix Pharmaceuticals Holding Corp. stock information by Barron's. View real-time TNXP stock price and news, along with industry-best analysis.